The Effect of Sacubitril/Valsartan Therapy on Hospitalization and Mortality in Patients Non-Respondent to Cardiac Resynchronization Therapy

被引：0
|
作者：
Szabo, Krisztina Maria
Toth, Anna Zsofia
Racz, Vivien
Nagy, Attila Csaba
Barta, Judit
Borbely, Attila
Csanadi, Zoltan
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Resynchronization therapy; Heart Failure; Outcomes;
D O I：
10.1161/circ.148.suppl_1.14660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14660
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The effects of sacubitril/valsartan on cardiac resynchronization therapy candidates
    Chang, H. Y. Hung-Yu
    Hsu, C. Y.
    Liao, C. T.
    Lee, Y. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 54 - 54
  • [2] Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy
    Huang, Hsin-Ti
    Huang, Jin-Long
    Lin, Po-Lin
    Lee, Ying-Hsiang
    Hsu, Chien-Yi
    Chung, Fa-Po
    Liao, Chia-Te
    Chiou, Wei-Ru
    Lin, Wen-Yu
    Liang, Huai-Wen
    Chang, Hung-Yu
    ESC HEART FAILURE, 2022, 9 (06): : 3825 - 3835
  • [3] The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non-responders: a retrospective analysis
    Chun, Kyeong-Hyeon
    Oh, Jaewon
    Yu, Hee Tae
    Lee, Chan Joo
    Kim, Tae-Hoon
    Uhm, Jae Sun
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    Kang, Seok-Min
    ESC HEART FAILURE, 2020, 7 (06): : 4404 - 4407
  • [4] Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients
    Fonderico, Celeste
    Pergola, Valerio
    Faccenda, Daniele
    Salucci, Alfonsomaria
    Comparone, Gianluigi
    Marrese, Aldo
    Ammirati, Giuseppe
    Cocchiara, Luigi
    Varriale, Alfonso
    Esposito, Giovanni
    Rapacciuolo, Antonio
    Strisciuglio, Teresa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [5] Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization
    Szabo, Krisztina Maria
    Toth, Anna
    Nagy, Laszlo
    Racz, Vivien
    Polik, Zsofia
    Hodosi, Katalin
    Nagy, Attila C.
    Barta, Judit
    Borbely, Attila
    Csanadi, Zoltan
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 149 - 161
  • [6] Add-on Sacubitril/Valsartan Therapy Induces Left Ventricular Remodeling in Non-responders to Cardiac Resynchronization Therapy to a Similar Extent as in Heart Failure Patients Without Resynchronization
    Krisztina Mária Szabó
    Anna Tóth
    László Nagy
    Vivien Rácz
    Zsófia Pólik
    Katalin Hodosi
    Attila C. Nagy
    Judit Barta
    Attila Borbély
    Zoltán Csanádi
    Cardiology and Therapy, 2024, 13 : 149 - 161
  • [7] Hospitalization for heart failure following cardiac resynchronization therapy: Impact in mortality
    Trepa, M. Maria
    Santos, R. Baggen
    Silveira, I.
    Brochado, B.
    Oliveira, M. F.
    Gomes, C.
    Dias, V. A.
    Roque, C.
    Vieira, P. V.
    Reis, H.
    Torres, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 67 - 67
  • [8] The effect of sacubitril/valsartan on device detected arrhythmias and electrical parameters among cardiac resynchronization therapy implanted patients with moderately reduced ejection fraction
    Dussekeyeva, G. Gulnoza
    Rekvava, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 14 - 15
  • [9] Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction
    Yang, Pei
    Li, Xiaokang
    Wang, Lijin
    Wu, Xinlei
    Wang, Chiyao
    Li, Tian
    Wang, Haiyan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [10] Effect of Serum Creatinine on Mortality and Response to Cardiac Resynchronization Therapy
    Wang, Dongmei
    Han, Yaling
    Zang, Hongyun
    Yu, Haibo
    Zhang, Donghong
    Wang, Shouli
    Wang, Zulu
    Jing, Quanmin
    CIRCULATION, 2010, 122 (02) : E233 - E233
12345